Pumping it up: New advancements in insulin delivery

Haley Kessinger; Emily L. Knezevich; Edward DeSimone; Michael H. Davidian

Pumping it up: New advancements in insulin delivery

Haley Kessinger, Emily L. Knezevich, Edward DeSimone, Michael H. Davidian

Research output: Contribution to specialist publication › Article

Abstract

Continuous subcutaneous insulin infusion (CSII) devices, commonly referred to as insulin pumps, are a growing trend in diabetes care. Insulin pumps enable patients to program basal delivery of insulin per hour, as well as deliver boluses for food intake throughout the day. Benefits include better diabetes control, increased flexibility of basal delivery, precise bolus dosing, and improved quality of life. Limitations may include cost, insurance coverage, and fear of dependence; CSII has also been associated with infusion-site reactions, diabetic ketoacidosis, and retinopathy. A variety of pumps with features such as alarms, reminders, and Bluetooth connectivity are available. Pharmacists can play an important role in providing pump education and training for patients, as well as troubleshooting and pump management.

Original language	English (US)
Volume	42
No	11
Specialist publication	U.S. Pharmacist
State	Published - Nov 1 2017

All Science Journal Classification (ASJC) codes

Pharmacy
Pharmacology
Pharmaceutical Science

Fingerprint Dive into the research topics of 'Pumping it up: New advancements in insulin delivery'. Together they form a unique fingerprint.

Cite this

@misc{6f28ac16fb4d4075b40523ffe1067853,

title = "Pumping it up: New advancements in insulin delivery",

abstract = "Continuous subcutaneous insulin infusion (CSII) devices, commonly referred to as insulin pumps, are a growing trend in diabetes care. Insulin pumps enable patients to program basal delivery of insulin per hour, as well as deliver boluses for food intake throughout the day. Benefits include better diabetes control, increased flexibility of basal delivery, precise bolus dosing, and improved quality of life. Limitations may include cost, insurance coverage, and fear of dependence; CSII has also been associated with infusion-site reactions, diabetic ketoacidosis, and retinopathy. A variety of pumps with features such as alarms, reminders, and Bluetooth connectivity are available. Pharmacists can play an important role in providing pump education and training for patients, as well as troubleshooting and pump management.",

author = "Haley Kessinger and Knezevich, {Emily L.} and Edward DeSimone and Davidian, {Michael H.}",

year = "2017",

month = nov,

day = "1",

language = "English (US)",

volume = "42",

journal = "U.S. Pharmacist",

issn = "0148-4818",

publisher = "Jobson Publishing Corporation",

}

TY - GEN

T1 - Pumping it up

T2 - New advancements in insulin delivery

AU - Kessinger, Haley

AU - Knezevich, Emily L.

AU - DeSimone, Edward

AU - Davidian, Michael H.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Continuous subcutaneous insulin infusion (CSII) devices, commonly referred to as insulin pumps, are a growing trend in diabetes care. Insulin pumps enable patients to program basal delivery of insulin per hour, as well as deliver boluses for food intake throughout the day. Benefits include better diabetes control, increased flexibility of basal delivery, precise bolus dosing, and improved quality of life. Limitations may include cost, insurance coverage, and fear of dependence; CSII has also been associated with infusion-site reactions, diabetic ketoacidosis, and retinopathy. A variety of pumps with features such as alarms, reminders, and Bluetooth connectivity are available. Pharmacists can play an important role in providing pump education and training for patients, as well as troubleshooting and pump management.

AB - Continuous subcutaneous insulin infusion (CSII) devices, commonly referred to as insulin pumps, are a growing trend in diabetes care. Insulin pumps enable patients to program basal delivery of insulin per hour, as well as deliver boluses for food intake throughout the day. Benefits include better diabetes control, increased flexibility of basal delivery, precise bolus dosing, and improved quality of life. Limitations may include cost, insurance coverage, and fear of dependence; CSII has also been associated with infusion-site reactions, diabetic ketoacidosis, and retinopathy. A variety of pumps with features such as alarms, reminders, and Bluetooth connectivity are available. Pharmacists can play an important role in providing pump education and training for patients, as well as troubleshooting and pump management.

UR - http://www.scopus.com/inward/record.url?scp=85035030506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035030506&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85035030506

VL - 42

JO - U.S. Pharmacist

JF - U.S. Pharmacist

SN - 0148-4818

ER -